Sort
51,593 grants matching “hepatitis”
Mechanisms of Hepatitis C Virus Evolution
$517,928Stuart C Ray · Johns Hopkins University · R01 · FY2009 · DA
Targeted-and Image-Based Adenovirus Cancer Therapeutic Vectors
$517,924David T Curiel · Washington University · R01 · FY2011 · CA
Inflammation, Macrophage Differentiation, and Cancer
$517,920Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Mechanisms of Hepatitis C Virus Evolution
$517,865Stuart C Ray · Johns Hopkins University · R01 · FY2007 · DA
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle
$517,789Stacy Michelle Horner · Duke University · R01 · FY2016 · AI
Alcohol and Chronic Disease Among Vulnerable Populations
$517,782Harvard University (Sch Of Public Hlth) · R01 · FY2004 · AA
Ketone Body Metabolism and Integrated Metabolic Homeostasis
$517,700Peter A Crawford · University Of Minnesota · R01 · FY2022 · DK
Intervention to Reduce Injection Drug Use
$517,628Robert E Booth · University Of Colorado Denver · R01 · FY2008 · DA
Exome Sequencing to Identify CVD Risk Variants in Hispanics & African Americans
$517,475Donald W. Bowden · Wake Forest University Health Sciences · R01 · FY2012 · HG
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis
$517,394Yan Shu · University Of Maryland Baltimore · R01 · FY2024 · DK
Functional and structural correlates of PCSK9 association with lipoproteins
$517,392Nathalie Pamir · Oregon Health & Science University · R01 · FY2021 · HL
The role of H3K4 demethylases in alcohol-associated liver disease development and resolution
$517,379Irina Tikhanovich · University Of Kansas Medical Center · R01 · FY2024 · AA
Investigation of ACAT Functions Using Knockout
$517,352Robert V Farese · J. David Gladstone Institutes · R01 · FY2006 · HL
Role of Neutralizing Antibodies in Transmission of SHIV
$517,305Nancy Logan Haigwood · Seattle Biomedical Research Institute · R01 · FY2007 · HD
Imaging Brain Signal Transduction via Arachidonic and Docosahexaenoic Acids
$517,300Stanley I Rapoport · National Institute On Aging · ZIA · FY2011 · AG
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$517,286Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2022 · DK
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$517,284Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2023 · DK
MRP4 in Drug Sensitivity and Physiology
$517,263John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2010 · GM
HCC diagnostics defined by fucosylated serum biomarkers
$517,164Anand S Mehta · Immunotope, Inc. · R42 · FY2009 · CA
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
$517,117Klaus H. Kaestner · University Of Pennsylvania · R01 · FY2024 · CA
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$517,066Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2025 · DK
Mechanisms linking the Branched-Chain alpha-Keto Acid regulatory network to the pathogenesis of NASH
$517,029Phillip J White · Duke University · R01 · FY2024 · DK
THALASSEMIA CLINICAL RESEARCH NETWORK - DCC
$516,991New England Research Institutes, Inc. · U01 · FY2003 · HL
Carbohydrate-Mediated Platelet Clearance
$516,972Karin Maria Hoffmeister · Versiti Wisconsin, Inc. · R01 · FY2023 · HL
MOLECULAR MECHANISMS OF CHEMOPREVENTION--DITHIOLETHIONES
$516,964Johns Hopkins University · R01 · FY2002 · CA